Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hahn

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
Blood Advances|March 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutationsMithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Blood Cancer Journal|May 7, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohortMithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Haematologica|July 8, 2021
The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancyClaire C Homan, Sarah L King-Smith, David M Lawrence, et al.
Journal of Medicinal Chemistry|October 24, 2024
The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin αvβ6 Inhibitor for FibrosisBryce A Harrison, James E Dowling, Matthew G Bursavich, et al.
Blood Advances|April 25, 2024
Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansionParvathy Venugopal, Peer Arts, Lucy C Fox, et al.
Nature Genetics|March 31, 2019
Genomic subtyping and therapeutic targeting of acute erythroleukemiaIlaria Iacobucci, Ji Wen, Manja Meggendorfer, et al.
Blood|July 11, 2024
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predispositionJiarna R Zerella, Claire C Homan, Peer Arts, et al.
Blood Advances|March 26, 2020
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AMLAnna L Brown, Peer Arts, Catherine L Carmichael, et al.
Blood Advances|July 5, 2023
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41Claire C Homan, Michael W Drazer, Kai Yu, et al.
Nature Genetics|September 10, 2013
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemiaSohela Shah, Kasmintan A Schrader, Esmé Waanders, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Blood Advances|March 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutationsMithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Blood Cancer Journal|May 7, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohortMithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Haematologica|July 8, 2021
The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancyClaire C Homan, Sarah L King-Smith, David M Lawrence, et al.
Journal of Medicinal Chemistry|October 24, 2024
The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin αvβ6 Inhibitor for FibrosisBryce A Harrison, James E Dowling, Matthew G Bursavich, et al.
Blood Advances|April 25, 2024
Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansionParvathy Venugopal, Peer Arts, Lucy C Fox, et al.
Nature Genetics|March 31, 2019
Genomic subtyping and therapeutic targeting of acute erythroleukemiaIlaria Iacobucci, Ji Wen, Manja Meggendorfer, et al.
Blood|July 11, 2024
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predispositionJiarna R Zerella, Claire C Homan, Peer Arts, et al.
Blood Advances|March 26, 2020
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AMLAnna L Brown, Peer Arts, Catherine L Carmichael, et al.
Blood Advances|July 5, 2023
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41Claire C Homan, Michael W Drazer, Kai Yu, et al.
Nature Genetics|September 10, 2013
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemiaSohela Shah, Kasmintan A Schrader, Esmé Waanders, et al.
Pageof 21